Commentary: Lessons from the COVID-19 global health response to inform TB case finding.
Healthc (Amst)
; 9(2): 100487, 2021 Jun.
Article
in English
| MEDLINE | ID: covidwho-885287
ABSTRACT
The coronavirus disease 2019 (COVID-19) has emerged as a serious threat to global public health, demanding urgent action and causing unprecedented worldwide change in a short space of time. This disease has devastated economies, infringed on individual freedoms, and taken an unprecedented toll on healthcare systems worldwide. As of 1 April 2020, over a million cases of COVID-19 have been reported in 204 countries and territories, resulting in more than 51,000 deaths. Yet, against the backdrop of the COVID-19 pandemic, lies an older, insidious disease with a much greater mortality. Tuberculosis (TB) is the leading cause of death by a single infectious agent and remains a potent threat to millions of people around the world. We discuss the differences between the two pandemics at present, consider the potential impact of COVID-19 on TB case management, and explore the opportunities that the COVID-19 response presents for advancing TB prevention and control now and in future.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Tuberculosis
/
Communicable Disease Control
/
Global Health
/
COVID-19
/
Health Services Accessibility
Type of study:
Observational study
Limits:
Humans
Language:
English
Journal:
Healthc (Amst)
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS